ES371093A1 - Un procedimiento de preparacion de nuevos productos deriva-dos del acido glioxilico. - Google Patents

Un procedimiento de preparacion de nuevos productos deriva-dos del acido glioxilico.

Info

Publication number
ES371093A1
ES371093A1 ES371093A ES371093A ES371093A1 ES 371093 A1 ES371093 A1 ES 371093A1 ES 371093 A ES371093 A ES 371093A ES 371093 A ES371093 A ES 371093A ES 371093 A1 ES371093 A1 ES 371093A1
Authority
ES
Spain
Prior art keywords
preparation
composition containing
glyoxylic acid
containing same
heterocyclic derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES371093A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOUDE LAB
Original Assignee
HOUDE LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOUDE LAB filed Critical HOUDE LAB
Publication of ES371093A1 publication Critical patent/ES371093A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ES371093A 1968-09-02 1969-09-01 Un procedimiento de preparacion de nuevos productos deriva-dos del acido glioxilico. Expired ES371093A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR164817A FR7736M (enExample) 1968-09-02 1968-09-02

Publications (1)

Publication Number Publication Date
ES371093A1 true ES371093A1 (es) 1971-08-16

Family

ID=8654167

Family Applications (1)

Application Number Title Priority Date Filing Date
ES371093A Expired ES371093A1 (es) 1968-09-02 1969-09-01 Un procedimiento de preparacion de nuevos productos deriva-dos del acido glioxilico.

Country Status (5)

Country Link
BE (1) BE737674A (enExample)
DE (1) DE1944121A1 (enExample)
ES (1) ES371093A1 (enExample)
FR (1) FR7736M (enExample)
GB (1) GB1247306A (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
US7704993B2 (en) 2003-06-17 2010-04-27 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
SI2332921T1 (sl) 2003-06-17 2016-06-30 Arena Pharmaceuticals, Inc. 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid
CA2589988C (en) 2004-12-21 2017-02-14 Arena Pharmaceuticals, Inc. Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
PT1833473E (pt) 2004-12-23 2009-12-17 Arena Pharm Inc Composições de modulador de receptor 5ht2c e métodos de utilização
EP2518053A1 (en) 2006-04-03 2012-10-31 Arena Pharmaceuticals, Inc. Process for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
EP2099743B1 (en) 2006-12-05 2014-08-27 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
JP5491421B2 (ja) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストである(r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンに関連する中間体の調製のためのプロセス
CN102648170A (zh) 2009-06-18 2012-08-22 艾尼纳制药公司 制备5-ht2c受体激动剂的方法
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
WO2012030957A2 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
CN103347523A (zh) 2010-09-01 2013-10-09 艾尼纳制药公司 向具有肾损伤的个体给药氯卡色林
MX2013002422A (es) 2010-09-01 2013-05-17 Arena Pharm Inc Sales de lorcaserina con acidos opticamente activos.
KR20180118801A (ko) 2010-09-01 2018-10-31 에자이 알앤드디 매니지먼트 가부시키가이샤 체중 관리에 유용한 5-ht2c 작동제의 변형-방출 투여 형태
WO2014058441A1 (en) 2012-10-09 2014-04-17 Arena Pharmaceuticals, Inc. Method of weight management

Also Published As

Publication number Publication date
FR7736M (enExample) 1970-03-09
DE1944121A1 (de) 1970-03-19
GB1247306A (en) 1971-09-22
BE737674A (enExample) 1970-02-02

Similar Documents

Publication Publication Date Title
ES371093A1 (es) Un procedimiento de preparacion de nuevos productos deriva-dos del acido glioxilico.
GB1432576A (en) Substituted phenylacetic acids
ES449162A1 (es) Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico.
ES448394A1 (es) Procedimiento para la obtencion de esteres de alcoxialquil- hidropiridina.
GB1355147A (en) Oxoprostanoic acid derivatives
ES8600751A1 (es) Procedimiento de producir derivados de acido oxazolacetico.
ES380859A1 (es) Un procedimiento para la preparacion de derivados de diben-zo-dioxocin.
GB1252329A (enExample)
GB1314830A (en) Pharmaceutically useful benzomorphanes and their production
GB1424415A (en) Prostaglandin intermediates and their preparation
GB1432503A (en) Cycloalkylalkylesters and process for their preparation
ES368929A1 (es) Procedimiento para la preparacion de acidos acetoaceticos.
GB1378068A (en) Citric acid derivatives
ES435604A1 (es) Procedimiento para la preparacion de derivados de indolila- cetilaminoacidos.
FR2445314A1 (fr) Procede de preparation d'acide 2-(3-phenoxy-phenyl)-propionique
GB1411700A (en) Penicillins and production thereof
JPS5764655A (en) Novel benzoylaminophenylcarboxylic acid derivative, its preparation, and drug composition comprising it
ES420666A1 (es) Procedimiento para preparar derivados de acidos (1-metil-5-nitro-2-imidazolil)tioalcanoicos.
GB1283900A (en) Therapeutically useful compounds and process for their preparation
JPS5265222A (en) Preparation of phosphoric acid ester having perfluoroalkyl group
JPS57212137A (en) Preparation of phenyl aliphtic acid derivative
ES446764A2 (es) Procedimiento para la obtencion de derivados del acido fenoxi-acetico.
JPS5265251A (en) Synthesis of prostaglandin derivatives
GB1362955A (en) Omega - homo - prostaglandin e1 heptyl ester and production thereof
FI833760A0 (fi) Foerfarande foer framstaellning av n-fosfonometylglycin